LGC Genomics said last week that it has expanded its nucleic acid extraction services to North America through the group's genomics laboratory in Beverly, Mass.
The new extraction service will complement existing capacity in Berlin and London, LGC said.
LGC Genomics is the genomics division of the international laboratory services firm LGC Group. Following a merger with KBioscience in 2011, the combined LGC Genomics business now provides a full range of genomics products and services including sample preparation (primarily nucleic acid extraction), sequencing, genotyping, and biobanking. The company's nucleic acid extraction technologies include Sbeadex and Kleargene, as well as instruments that enable automation.
The Beverly lab, established in 2011, has been providing genotyping services based on the company’s proprietary KASP genotyping technology, and will begin extraction operations early this year. The expanded service capability will enable a more comprehensive genomics project support service for customers in the North American market, LGC Genomics said.